secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001171843-26-000643
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical announces PRO FAMILIA hospital completes 500th Sonalleve procedure
--------------------------------------------------------------------------------

- PRO FAMILIA Specialist Hospital in Rzeszów, Poland performed its 500th Sonalleve MRI-guided focused ultrasound procedure.
- Sonalleve provides non-surgical treatment for uterine fibroids and adenomyosis, with no incisions, no blood loss, and no overnight stay.
- Over 4,000 women treated globally with 10 Sonalleve devices in Europe, China, and Southeast Asia.
- CEO Arun Menawat notes Sonalleve international growth while U.S. focus remains on TULSA-PRO commercialization.
- Approximately $10 million in research grants from European and Canadian organizations over five years for Sonalleve studies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326000643/0001171843-26-000643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326000643/f8k_020526.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-000643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer